The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Open accessAbstract
Aims A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp). Materials and methods In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin. Key findings The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease. Significance The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density-functional thermochemistry. III. The role of exact exchange
Becke, A. D. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464913 · Cited by 103,767
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku340 · Cited by 4,632
MolProbity: More and better reference data for improved all‐atom structure validation
Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., et al. (2018) · Protein Science · doi:10.1002/pro.3330 · Cited by 4,599
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Stewart, J. J. P. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-007-0233-4 · Cited by 3,619
Announcing the worldwide Protein Data Bank
Berman, H., Henrick, K., & Nakamura, H. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1203-980 · Cited by 3,093
PLIP: fully automated protein–ligand interaction profiler
Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv315 · Cited by 2,340
[20] VERIFY3D: Assessment of protein models with three-dimensional profiles
Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77022-8 · Cited by 2,192
Hooft, R. W. W., Vriend, G., Sander, C., & Abola, E. E. (1996) · Nature · doi:10.1038/381272a0 · Cited by 2,173
Molecular Modelling: Principles and Applications
Leach, A. R. (1996) · Cited by 1,945
Molecular Modelling: Principles and Applications
Valverde, J. R. (2001) · Briefings in Bioinformatics · doi:10.1093/bib/2.2.199 · Cited by 1,842
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U. G., & Khan, K. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa008 · Cited by 898
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
Kirchdoerfer, R. N., & Ward, A. B. (2019) · Nature Communications · doi:10.1038/s41467-019-10280-3 · Cited by 896
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., Hindes, R. G., & Berrey, M. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208953 · Cited by 764
Deviations from Standard Atomic Volumes as a Quality Measure for Protein Crystal Structures
Pontius, J., Richelle, J., & Wodak, S. J. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0628 · Cited by 736
COVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.026 · Cited by 509
Self-citationMiddle East Respiratory Syndrome Coronavirus (MERS-CoV)
Jolly, G. (2016) · TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH · doi:10.21522/tijph.2013.04.04.art033 · Cited by 441
The Middle East Respiratory Syndrome Coronavirus ( MERS - COV )
Jahan, F., & Al Maqbali, A. A. (2015) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2015.92625 · Cited by 334
Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
Murakami, E., Tolstykh, T., Bao, H., Niu, C., Steuer, H. M. M., Bao, D., Chang, W., Espiritu, C., Bansal, S., Lam, A. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161802 · Cited by 291
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, C. Q., de Melo, G. R., de Freitas, C. S., Rocha, N., Hoelz, L. V. B., Miranda, M., Fintelman-Rodrigues, N., Marttorelli, A., Ferreira, A. C., Barbosa-Lima, G., et al. (2017) · Scientific Reports · doi:10.1038/srep40920 · Cited by 247
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Bullard-Feibelman, K. M., Govero, J., Zhu, Z., Salazar, V., Veselinovic, M., Diamond, M. S., & Geiss, B. J. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.023 · Cited by 246
The clinical pharmacology of ribavirin.
Glue, P. (1999) · PubMed · Cited by 217
The mechanism of action of T7 DNA polymerase
Doublié, S., & Ellenberger, T. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80089-4 · Cited by 193
Báez-Santos, Y. M., Mielech, A. M., Deng, X., Baker, S. C., & Mesecar, A. D. (2014) · Journal of Virology · doi:10.1128/jvi.01294-14 · Cited by 133
Elfiky, A. A., Mahdy, S. M., & Elshemey, W. M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24736 · Cited by 128
Self-citationZika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
Elfiky, A. A. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24678 · Cited by 81
Self-citationSofosbuvir, a Significant Paradigm Change in HCV Treatment
McQuaid, T. J., Savini, C. J., & Seyedkazemi, S. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00041 · Cited by 75
Some One Health based control strategies for the Middle East respiratory syndrome coronavirus
Hemida, M. G., & Alnaeem, A. A. (2019) · One Health · doi:10.1016/j.onehlt.2019.100102 · Cited by 57
Pneumonia in China: lack of information raises concerns among Hong Kong health workers
Parry, J. (2020) · BMJ · doi:10.1136/bmj.m56 · Cited by 55
Applications of computer-aided approaches in the development of hepatitis C antiviral agents
Ganesan, A., & Barakat, K. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1291628 · Cited by 54
Elfiky, A. A., & Elshemey, W. M. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24934 · Cited by 54
Self-citationElfiky, A. A., & Ismail, A. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116958 · Cited by 52
Self-citationElfiky, A. A., & Ismail, A. M. (2018) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2018.1454981 · Cited by 43
Self-citationStructural properties of metal-free apometallothioneins
Summers, K. L., Mahrok, A. K., Dryden, M. D. M., & Stillman, M. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.141 · Cited by 39
Elfiky, A. A. (2017) · Future Virology · doi:10.2217/fvl-2017-0081 · Cited by 36
Self-citationElfiky, A. A., & Ibrahim, N. S. (2020) · doi:10.21203/rs.2.23280/v1 · Cited by 31
Self-citation
Cited by
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
Adasme, M. F., Linnemann, K. L., Bolz, S. N., Kaiser, F., Salentin, S., Haupt, V. J., & Schroeder, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab294 · Cited by 1,999
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,114
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
Metadata
- Authors
- Elfiky, A. A.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 248
- Pages
- 117477
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W3007227604
- Cited by
- 715
- References
- 43
- FWCI
- 20.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.